James M. Brimson
Bangkok, 10330, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Multi-Targeted Neuroprotection by Areca catechu Against Cisplatin-Induced Neurotoxicity: Cellular, Caenorhabditis elegans, and Metabolomic Evidence.
Journal: International journal of molecular sciences
Published: June 27, 2026
Synergistic Induction of Caspase-8-Mediated Leukaemic Cell Death by Fisetin and Pinocembrin.
Journal: International journal of molecular sciences
Published: May 13, 2026
Sigma-1 Receptor antagonism potentiates siramesine-induced apoptosis and altered autophagic signaling in human leukemia cells.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 11, 2026
Chemotherapy-induced peripheral neuropathy: Mechanisms of toxicity and potential natural compounds-based therapeutics.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: March 13, 2026
Sigma-1 Receptor Ligand Blarcamesine (ANAVEX 2-73) for Alzheimer's Disease: A Systematic Review.
Journal: CNS drugs
Published: February 06, 2026
Effects of rhodamine B on neuronal behavior and physiological function in the F1 generation of Danio rerio.
Journal: Environmental science and pollution research international
Published: May 22, 2025
Rhodamine-B induces amyotrophic lateral sclerosis symptoms like -behaviours in zebrafish.
Journal: Aquatic toxicology (Amsterdam, Netherlands)
Published: May 01, 2025
Agarwood leaf ethanol extract provides neuroprotective properties and promotes cholinergic differentiation of HT22 hippocampal neurons.
Journal: Scientific reports
Published: December 22, 2024
CT1812, a Small Molecule Sigma-2 Receptor Antagonist for Alzheimer's Disease Treatment: A Systematic Review of Available Clinical Data.
Journal: Journal of Alzheimer's disease : JAD
Published: October 18, 2024
Ligand docking in the sigma-1 receptor compared to the sigma-1 receptor-BiP complex and the effects of agonists and antagonists on C. elegans lifespans.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 08, 2024
Author Correction: A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications.
Journal: Scientific reports
Published: July 22, 2024
Last Updated: 09/26/2026